Healthcare marketing fails when it borrows playbooks from unregulated industries. Protected health information cannot be retargeted casually, clinical claims must be substantiated, and the real buyer is often a referring physician or a payer committee, not a patient clicking an ad. A fractional CMO for healthcare builds a system that earns trust at the speed regulators allow: evidence-led content, reputation and review management, referral-source marketing, and HIPAA-aware lead capture that legal will actually approve.
A fractional CMO for healthcare is a part-time Chief Marketing Officer who builds patient- and provider-facing demand while staying inside HIPAA, FDA promotional, and state advertising rules. Healthcare buyers move on trust, clinical evidence, and referral relationships rather than hype, so the marketing system is built around credible content, reputation, and compliant lead capture. Mark Gabrielli builds the demand engine, the compliance guardrails, and the reporting that healthcare boards and investors expect.
The CMO designs the funnel so that protected health information never touches an ad platform or analytics pixel that lacks a Business Associate Agreement. That means consented first-party data, compliant forms, conversion tracking that strips PHI, and a content strategy that drives demand without naming conditions tied to an identifiable person. Compliance is built into the architecture up front, not bolted on after legal flags a campaign — which is the difference between marketing that scales and marketing that gets shut down.
Trust compounds slower than clicks in healthcare, so the channels that work are the ones that build durable credibility: clinical and educational content that ranks and gets cited, physician-referral marketing, reputation and review systems, and account-based outreach to payers or health systems. Paid acquisition plays a supporting role, but the core asset is authority — being the source patients and referrers trust. A fractional CMO builds that owned authority so acquisition cost falls over time instead of rising.
Before a repeatable go-to-market motion is proven, a fractional CMO is the right call. Digital health startups often burn a full-time VP budget testing channels that a senior operator could have ruled out in a sprint. A fractional CMO establishes the ICP (patient, provider, or payer), validates the acquisition motion, builds the compliant infrastructure, and only then defines the in-house team to hire — so the first full-time marketing dollars are spent on a proven system, not an experiment.
Organic search and educational content lead, because they capture intent (patients and referrers searching for conditions, procedures, and providers) without touching protected health information. Reputation and review systems on Google and health-specific directories drive trust and local visibility. Referral-source marketing — content and outreach aimed at referring physicians — is often the highest-value channel for specialists. Paid search works when conversion tracking is architected to strip PHI. What rarely works without legal risk is broad behavioral retargeting tied to condition pages, which is why the channel mix is designed around consented, first-party, intent-driven demand.
They are two different go-to-market motions. Selling to providers and health systems is B2B: long cycles, clinical and economic buyers, procurement and security review, and proof of outcomes and ROI — won with authority content, case evidence, and account-based outreach. Selling to patients is consumer healthcare: trust, education, reputation, and a frictionless, compliant conversion path. A fractional CMO defines which motion (or both) the product needs, then builds the distinct demand systems for each rather than forcing one playbook onto fundamentally different buyers.
The specific systems this vertical needs — built and owned by your team, not rented.
Forms, tracking, and CRM architected so PHI never reaches a non-BAA platform.
Evidence-led pages that rank for what patients and referrers actually search.
Review generation and management across Google and healthcare directories.
Content and outreach that win referring-physician relationships.
Distinct positioning and journeys for clinical buyers and consumers.
Board-ready reporting that proves marketing ROI without exposing PHI.
The numbers a fractional CMO is held accountable to in this industry.
Every claim is tied to clinical data or outcomes. This is what ranks, what referrers respect, and what survives regulatory review.
For providers, the highest-value 'customer' is often another clinician. We build the content and outreach that wins referral relationships, not just patient clicks.
Conversion tracking and CRM are architected so PHI never leaks into ad or analytics platforms — marketing you can scale without legal risk.
Mark also serves these verticals with dedicated marketing leadership:
Transparent, no lock-in pricing. Start with a sprint or move straight to a retainer. Month-to-month after the first 90 days.
Free Strategy Call
No pitch. No deck. A direct 30-minute conversation about your biggest commercial challenge and exactly what to do about it.
C-suite marketing leadership for healthcare — without the C-suite cost. Starting at $8K/month.